Business Advisory Firm
Investing in
Your Future
Investing in
Your Future
WE ARE FIRST CLASS CROSS BORDERS ADVISORY FIRM
W
Solomon Capital Group is one of the top Cross-Border Advisory firms. Over the years, over the years we have served more than 600 corporations, financial institutions, and government offices. We have a strong presence in Tel Aviv-Dubai-London-Abu Dhabi. We provide premium investment banking and business advisory services, and most professional financial services.
רוצים גם אתם תכנית עסקית שמייצרת תוצאות?השאירו פרטים ונחזור אליכם לתיאום פגישה
Business Advisory Firm
We are First-Class Cross-Border Business Advisory Firm
W
Solomon Capital Group is one of the top Cross-Border Advisory firms. Over the years, over the years we have served more than 600 corporations, financial institutions, and government offices. We have a strong presence in Tel Aviv-Dubai-London-Abu Dhabi. We provide premium investment banking and business advisory services, and most professional financial services.
ABOUT DAVID SOLOMON
David is the founder and active chairman at Solomon Capital, a leading cross-borders group providing investment banking advisory services as well as corporate finance services that include; advisory services for Fundraising, M&A, Financial Restructuring, and Business Strategy Consulting to Israeli, and International companies.
With over 25 years of experience, David Solomon is one of the leading experts in the field of Corporate Finance. David is the former Managing Partner of Cukierman & Co. Consulting Ltd, the founder and the CEO of B-PLAN, 4HIGHTECH [Investment Bank], and Micromedic Technologies [Listed on the Tel Aviv Stock Exchange.].
Mr. Solomon has worked with high-profile clients in the global market such as IBM, Scitex, Bezeq, Bank Discount, Bank Hapoalim, Bank Leumi, Israel Aerospace Industries [IAI], QUALCOMM, Dor Energy, RAPAK UK NHS, Gama UK, B-Plan UK and others.
Mr. Solomon lectures in Courses in academic and other institutes. David is the author of various books, including: "From Seed IPO", "Business Planning in the Post Bubble Era", and "Biomedical - from Research to Market, The Business Challenge".
..
